Ind-Swift Laboratories is trading at ₹364.00, up +5.89%, with no reliable report identifying a specific November 4 catalyst.
- The latest identified company updates were monitoring-agency filings on November 3.
- An investor call about the September-quarter results was scheduled for November 4.
- Q2 FY27 revenue rose 50.15% and net profit reached ₹31.03 crore; available sources do not establish that these results caused the move.